Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

14.190
+0.0100.07%
Volume:294.00K
Turnover:4.16M
Market Cap:23.07B
PE:6.64
High:14.230
Open:14.230
Low:14.130
Close:14.180
52wk High:19.716
52wk Low:14.000
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:2.03
T/O Rate:0.13%
Dividend:0.96
Dividend Rate:6.73%
EPS(LYR):2.139
ROE:6.50%
ROA:2.08%
PB:0.51
PE(LYR):6.64
PS:0.25

Loading ...

GPHL Hosts Global Investment Conference in Singapore, Launches WALOVI International Headquarters

Deep News
·
Yesterday

BAIYUNSHAN PH Gets Nod for Norepinephrine Bitartrate Injection Consistency Assessment

Stock News
·
Yesterday

Hong Kong Stock Flash | Baiyunshan (00874) Drops Nearly 6% After Results, Net Profit Falls 16.7% in H1 Due to Higher R&D Spending

Stock News
·
Yesterday

Guangzhou Baiyunshan Pharma's Profit Falls 17% in H1

MT Newswires Live
·
Yesterday

BAIYUNSHAN PH Reports Interim Results with Net Profit Attributable to Shareholders of Approximately RMB 2.096 Billion, Down 16.7% Year-on-Year

Stock News
·
Aug 21

Guangzhou Baiyunshan Unit Secures Australian TGA Recertification, Reinforcing Global Quality Standards

Deep News
·
Aug 20

Baiyunshan Pharmaceutical Subsidiary Gets China Supplementary Drug Nod for Brain Injury Injection

MT Newswires Live
·
Aug 20

BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths

Stock News
·
Aug 19

Baiyunshan Pharmaceutical's Unit Gets Macao Drug Regulator's Nod for Cefazolin Sodium for Injection

MT Newswires Live
·
Aug 18

BAIYUNSHAN PH Subsidiary Secures Pharmaceutical Registration Certificate from Macau Health Regulator

Stock News
·
Aug 17

Earning Preview: BAIYUNSHAN PH EPS expected to decline 4.44% YoY, institutional commentary remains muted

Earnings Agent
·
Aug 15

Baiyunshan Launches Sugar-Free Gold Edition Banlangen Granules

Deep News
·
Aug 13

Baiyunshan Pharmaceutical Gets Nod to Trial New Indication for Zhangyanming Tablets

MT Newswires Live
·
Aug 11

Guangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results

Bulletin Express
·
Aug 10

Baiyunshan Pharmaceutical Sets 28 Aug 2026 EGM to Approve New Director Pay Framework

Bulletin Express
·
Aug 07

Baiyunshan Pharma Schedules First Extraordinary General Meeting of 2026 to Approve Directors’ Remuneration Measures

Bulletin Express
·
Aug 07

Baiyunshan Pharmaceutical Subsidiary Receives Revised Drug Manufacturing License

MT Newswires Live
·
Aug 05

Baiyunshan Pharmaceutical Gets Macau Approval for Cefalexin Capsules

MT Newswires Live
·
Jul 21

Baiyunshan's Subsidiary Secures Macau Registration for Cefalexin Capsules

Stock News
·
Jul 20

Hong Kong Market Analysis: Capital Shifts from Tech to Biotech Amid Liquidity Drain and Sector Rotation

Stock News
·
Jul 10